Coya Therapeutics, Inc. (COYA) NASDAQ

5.47

-0.08(-1.44%)

Updated at December 26 04:00PM

Currency In USD

Valuation

Market Cap87.32M
Enterprise Value48.98M
P/E Ratio-0.01
PEG Ratio0
Price/Sales Ratio214.63
Price/Book Ratio0
Enterprise/Revenue-70,058.57
Enterprise/EBITDA4.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-14,427.19
Operating Margin-15,186.43

Management Effectiveness

Return On Assets-0.18
Return On Equity-0.86

Income Statement

Revenue3.55M
Revenue/Share0.03
Gross Profit-8.31M
EBITDA-17.2M
Net Income-14.88M
Diluted EPS-0.98

Balance Sheet

Total Cash28.13M
Total Cash/Share1,779.21
Total Debt0
Total Debt/Equity0
Current Ratio7.43
Book Value Per Share1,692.69

Price History

52-Week Change-5.85
52-Week High8.29
52-Week Low4.65
Moving Average 50 Days6.06
Moving Average 200 Days6.03

Statistics

Average Volume214,336
Shares Outstanding16.62M
% Held by Institutions28.44

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A